articleJournal of Pharmaceutical InvestigationMar 25, 2025Closed access

Disulfide bond-driven nanoassembly of lipophilic epirubicin prodrugs for breast cancer therapy

HYHaimeng YuanYCYao ChenYHYuting HuYLYanxin LiHZHongyuan Zhang

Shenyang Pharmaceutical University · Liaoning Cancer Hospital & Institute · +4 more institutions

Indexed incrossref

Abstract

No abstract available for this paper.

Citation impact

80
total citations
FWCI
42.09
Percentile
100%
References
39
Citations per year

Authors

12

Topics & keywords

Topics
Keywords
  • Prodrug
  • Epirubicin
  • Breast cancer
  • Chemistry
  • Disulfide bond
  • Cancer
  • Cancer therapy
  • Pharmacology
No related works found for this paper.

Funding